These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 26940959)
1. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases. Chung YL; Horng CF; Lee PI; Chen FL BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959 [TBL] [Abstract][Full Text] [Related]
2. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889 [TBL] [Abstract][Full Text] [Related]
3. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer. Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer. Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach. Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982 [TBL] [Abstract][Full Text] [Related]
9. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323 [TBL] [Abstract][Full Text] [Related]
10. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. Chen CC; Wang L; Lin JC; Jan JS J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974 [TBL] [Abstract][Full Text] [Related]
12. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081 [TBL] [Abstract][Full Text] [Related]
13. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer. Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282 [TBL] [Abstract][Full Text] [Related]
14. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325 [TBL] [Abstract][Full Text] [Related]
15. Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis. Jung J; Park G; Kim YS Anticancer Res; 2014 Aug; 34(8):4361-6. PubMed ID: 25075072 [TBL] [Abstract][Full Text] [Related]
16. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases. Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382 [TBL] [Abstract][Full Text] [Related]
17. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography. Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418 [TBL] [Abstract][Full Text] [Related]
18. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254 [TBL] [Abstract][Full Text] [Related]
19. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Chang AJ; Richardson S; Grigsby PW; Schwarz JK Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):263-9. PubMed ID: 21167656 [TBL] [Abstract][Full Text] [Related]
20. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy. Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]